Your Messages Inbox
Your Article Summary
See Latest ArticlesBiosign supplies monitoring gear to pain study
Canadian Healthcare Technology, 09/08/09
Biosign Technologies Inc. has announced the commercial launch of its UFIT system in the medical research market. Under the terms of a purchase order from Algogene Pain Genetics, Biosign will supply UFIT devices and online test, measurement and analysis services to a study on chronic pain.
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09
FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
Gen-Probe, 10/30/09
Gyrus PlasmaKinetic bipolar coagulation device for liver resection
Australian and New Zealand Journal of Surgery, 11/13/09
Article Search
Sponsor